Active surveillance up in multidisciplinary prostate CA care

Active surveillance up in multidisciplinary prostate CA care
Men with low-risk prostate cancer are more likely to pursue active surveillance when seen at a multidisciplinary prostate cancer clinic rather than when they see individual specialists in sequential settings, according to a study published online July 30 in the Journal of Clinical Oncology.

(HealthDay) -- Men with low-risk prostate cancer are more likely to pursue active surveillance when seen at a multidisciplinary prostate cancer clinic rather than when they see individual specialists in sequential settings, according to a study published online July 30 in the Journal of Clinical Oncology.

To examine the factors associated with active surveillance in patients with low-risk prostate cancer, Ayal A. Aizer, M.D., M.H.S., of Massachusetts General Hospital in Boston, and colleagues conducted a study involving 701 men who were either treated at a multidisciplinary prostate cancer clinic with a team consisting of an urologist and radiation and medical oncologists, or who saw individual specialists sequentially.

The researchers found the crude rates of active surveillance to be almost double for those seen in the multidisciplinary clinic compared with those seen by individual physicians (43 versus 22 percent), while the proportion treated with or was reduced by about 30 percent. The pursuit of active surveillance was significantly associated with consultation at a multidisciplinary clinic (odds ratio [OR], 2.15), older age (OR, 1.09), unmarried status (OR, 1.66), increased Charlson comorbidity index (OR, 1.37), and fewer positive cores (OR, 0.92).

"In conclusion, our study indicates that multidisciplinary care is associated with a significantly increased rate of active surveillance in men with low-risk , a finding that may have an important clinical, social, and economic impact," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Active surveillance cost-effective for prostate cancer

Jul 13, 2012

(HealthDay) -- In a theoretical cohort of 120,000 men, selecting active surveillance for prostate cancer results in considerable cost savings at five and 10 years of follow-up, compared with immediate treatment, ...

Recommended for you

New paper describes how DNA avoids damage from UV light

4 hours ago

In the same week that the U.S. surgeon general issued a 101-page report about the dangers of skin cancer, researchers at Montana State University published a paper breaking new ground on how DNA – the genetic code in every ...

Drug target identified for common childhood blood cancer

5 hours ago

In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report that they have identified ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

JGE
not rated yet Aug 15, 2012
Now known to most scientific support morbildad caused by the procedures to diagnose and treat prostate cancer, active surveillance is a well indicated for selected patients. We need a report or report of consensus which categorically its indication and scope